Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Large-scale testing (Phase 3)Active Not RecruitingNCT06311721
What this trial is testing

Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
Amgen 315
Testing effectiveness (Phase 2)Study completedNCT03668847
What this trial is testing

DM-CHOC-PEN for Brain Tumors in AYA Subjects

Who this might be right for
Advanced CancerBrain Metastases
DEKK-TEC, Inc. 20
Testing effectiveness (Phase 2)UnknownNCT05007938
What this trial is testing

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Early research (Phase 1)Looking for participantsNCT07660432
What this trial is testing

SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Ended earlyNCT04971187
What this trial is testing

Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00194766
What this trial is testing

Continuous Temozolomide in Patients With Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer

Who this might be right for
Breast CancerSoft Tissue Sarcoma
University of Washington 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05010629
What this trial is testing

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Who this might be right for
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic Cancer+1 more
Glenn J. Hanna 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Large-scale testing (Phase 3)Study completedNCT00327769
What this trial is testing

Faslodex Advanced Breast Cancer Local Chinese Study

Who this might be right for
Advanced Breast Cancer
AstraZeneca 234
Early research (Phase 1)Study completedNCT00276302
What this trial is testing

Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
Infinity Pharmaceuticals, Inc. 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07420439
What this trial is testing

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Who this might be right for
Non Small Cell Lung Cancer MetastaticInterstitial Lung Disease (ILD)
Intergroupe Francophone de Cancerologie Thoracique 108
Testing effectiveness (Phase 2)UnknownNCT03662412
What this trial is testing

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Testing effectiveness (Phase 2)Ended earlyNCT02959554
What this trial is testing

Study in Which Therapy is Either Switched to Nivolumab After 3 Months of Treatment or Therapy is Continued With a Tyrosine Kinase Inhibitor in Patients With Metastatic Renal Cell Carcinoma (RCC) and Disease Control

Who this might be right for
Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 49
Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Large-scale testing (Phase 3)UnknownNCT02854072
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Samsung Pharmaceutical Co., Ltd. 148
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Next Page